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Chronic Salt Loading and the Expression of
Adenosine Receptor Subtypes
To the Editor:
We read with great interest the paper by Zou et al1 entitled “Effect
on Chronic Salt Loading on Adenosine Metabolism and Receptor
Expression in Renal Cortex and Medulla in Rats” in the January
1999 issue ofHypertensionregarding the effect of chronic salt
loading on adenosine metabolism and receptor expression in renal
cortex and medulla in rats. It was reported in this article that chronic
salt loading influences the expression of adenosine receptor sub-
types (A1, A2A, A2B, and A3) in the renal cortex and medulla. The
authors report that an immunoreactive band of 39 kDa was identi-
fied when the membranes were probed with anti-A1 receptor
antibody. Further, bands of 45 (A2AR), 50 (A2BR), and 52 kDa (A3R)
were detected when membranes were probed with anti-A2A, 2B,
and A3 receptor antibodies, respectively.
We believe that the molecular masses of A2BR and A3R are
totally incorrect and that the molecular mass of A1R is also
questionable. It has been reported2–6 that the molecular weights
of A2B, A3, and A1 receptor proteins are in the range of 36 to 37
kDa compared with 50, 52, and 39 kDa, respectively, as reported
in the Zou et al1 paper. Recently, in another study,6 the molecular
weight of the A2B adenosine receptor is being reported to be
different for the same antibody, which was obtained from Alpha
Diagnostics. This is quite disturbing and needs to be investigated
by scientists in the field, which are using these antibodies. We
are currently analyzing these antibodies for their specificity and
cross-reactivity using recombinant receptors expressing only
single receptor proteins. As far as we know, no investigator has
ever characterized these antibodies. Unless we have the data to
support that these antibodies are specific in nature, one has to be
very careful in reaching this conclusions since all the adenosine
receptors except A2A have the same molecular masses. Therefore,
in our opinion, it is possible that some non-specific protein bands
reported in the above study1 might have been detected by these
investigators1 in the range of 50 to 52 kDa due to the polyclonal
nature of antibodies. These bands have been misunderstood by
the authors as A2B, A3, and A1 proteins at 50, 52, and 39 kDa sizes
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Response
All antibodies used in our studies were purchased from Alpha
Diagnostics, Inc, which were purified by affinity chromatogra-
phy.1 When the membranes carrying renal cortical and medullary
tissue proteins were probed with these antibodies, only one single
dark immunoreactive band for each receptor was detected in the
whole membrane with a few exceptions in the renal medulla,
although we only presented a small part of each gel document in
order to incorporate 4 gels into one figure. The molecular sizes
of detected receptors were consistent with those indicated by the
manufacturer. The specificity of these antibodies was confirmed
by competing with excess corresponding peptides and recombi-
nant adenosine receptor proteins. We believe that the immuno-
reactive bands recognized by these antibodies represent corre-
sponding adenosine receptors.
Nayeem et al questioned the molecular masses of detected
adenosine receptors in our studies based on the predicted
molecular sizes of deduced amino acids from receptor cDNA
sequences, as indicated in those review articles cited by them. In
fact, the predicted molecular size of proteins deduced from
cDNA sequence does not necessarily represent the actual molec-
ular size of detected or purified proteins from a variety of tissues.
Since the splicing of RNA during transcription may produce
different sizes of mRNA in different tissues or different species
and since the posttranslational processing or membrane assembly
may alter the sizes of translated receptor proteins, it is not
surprising that actually detected receptor proteins by Western
blot analysis can exhibit different molecular sizes in different
tissues or species. With respect to adenosine receptors, only a
few studies using Western blot analyses (including our work
published in Hypertension1) have been done to detect their
expression. The results show that the molecular sizes of detected
adenosine receptors in different tissues are inconsistent and
different from the predicted sizes.1–4 In their own work, Marala
and Mustafa,4 the colleagues of Nayeem, have also reported that
the size of the detected A2A receptor by Western blotting was
different from the predicted size of this receptor.5 It is possible
that the heterogeneity of adenosine receptor expression, post-
translational processing, or membrane assembly may occur in
different tissues or species. The heterogeneity or differences
between predicted molecular size from deduced amino acids and
purified protein are also found in other proteins. For instance,
hypoxia-inducible factor-1a (HIF-1a), a transcription factor that
we have been working with, has a predicted size of 93 kD by
deduced amino acids, but purified or immunoreactive HIF-1a
protein is 120 kD.6,7 Therefore, the predicted molecular sizes of
36 to 37 kD based on A2B, A3, and A1 receptor cDNAs as cited
by Nayeem et al do not necessarily represent the sizes of purified
or immunoreactive receptor proteins, and we have confidence in
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